Results from Clinical Trial of COVID-19 Hyperimmune

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune …

CSL COVID19 Update

CSL continues to provide medicines to patients around the world.

A Research Catalyst in Switzerland

A new partnership between CSL Behring and Biopôle takes shape, pairing the global biotech with one of the most dynamic life s…

CSL CEO Paul Perreault on Rare Disease Day

See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”

Take the Rare Disease Day Quiz!

Test your knowledge about rare diseases, which affect more people than you think.

CSL Half Year Results 2020-21

CSL Delivers Net Profit of Over $ 1.8 Billion

What to Tell the Kids About COVID-19?

A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.

Unique in many ways

CSL Behring is one of the best employers in Switzerland. A glimpse behind the scenes.